PAI Holdings, LLC. dba Pharmaceutical Associates Inc recalls
Every recall we track for PAI Holdings, LLC. dba Pharmaceutical Associates Inc — 7 in all, from 2020–2025 — plus the complaints and injury reports the public filed about them.
Recalls per year, by danger level
7 recalls since 2017.
All FDA recall records for PAI Holdings, LLC. dba Pharmaceutical Associates Inc since 2017, counted by recall date (one bar per calendar year; 2026 is partial). Danger level is GovInfoNow’s plain-language rating; “not yet rated” records are still being written up.
| Year | Stop using now | Use caution | Lower risk | Not yet rated | Total |
|---|---|---|---|---|---|
| 2017 | 0 | 0 | 0 | 0 | 0 |
| 2018 | 0 | 0 | 0 | 0 | 0 |
| 2019 | 0 | 0 | 0 | 0 | 0 |
| 2020 | 0 | 0 | 3 | 0 | 3 |
| 2021 | 0 | 0 | 2 | 1 | 3 |
| 2022 | 0 | 0 | 0 | 0 | 0 |
| 2023 | 0 | 0 | 0 | 0 | 0 |
| 2024 | 0 | 0 | 0 | 0 | 0 |
| 2025 | 0 | 1 | 0 | 0 | 1 |
| 2026 (to date) | 0 | 0 | 0 | 0 | 0 |
What to do if you have a recalled PAI Holdings, LLC. dba Pharmaceutical Associates Inc product
- Match the NDC and lot number on your bottle or box to the recall.
- Don’t stop a prescription on your own — ask your pharmacist or doctor for a replacement first.
- Report side effects to FDA MedWatch.
All PAI Holdings, LLC. dba Pharmaceutical Associates Inc recalls
5 shown- Use cautionDrug
PAI Holdings, LLC. dba Pharmaceutical Associates Inc recalls Guaifenesin and Codeine Phosphate Oral Solution USP, 100mg/10 mg per 5 mL, 16 fl oz (473 ml) bottles, PAI
Pharmaceutical Associates recalls 4,080 bottles of Guaifenesin and Codeine Phosphate Oral Solution due to superpotent labeling issues.
Pharmaceutical AssociatesJan 7, 2025 - Lower riskDrug
PAI Holdings, LLC. dba Pharmaceutical Associates Inc recalls Ethosuximide Oral Solution USP 250 mg/5 mL, 16 fl oz (473 mL), Rx ONLY, Pharmaceutical Associates, Inc. Greenville, SC
Pharmaceutical Associates recalls Ethosuximide Oral Solution (250 mg/5 mL) due to potential carryover of Senna Syrup. This prescription medication may cause unintended effects if used without proper cleaning.
Pharmaceutical AssociatesJul 29, 2021 - Lower riskDrug
PAI Holdings, LLC. dba Pharmaceutical Associates Inc recalls Citalopram Oral Solution, USP 20 mg/10 mL, 10 mL unit dose cups, Rx Only, Mfg for: Pharmaceutical Associates, Inc.
Pharmaceutical Associates recalls 20 mg/10 mL citalopram oral solution due to impurities and degradation at 9 months. Affected lots expired by April 2021. Consumers should contact pharmacy for safe alternatives.
Pharmaceutical AssociatesSep 9, 2020 - Lower riskDrug
PAI Holdings, LLC. dba Pharmaceutical Associates Inc recalls Nystatin Oral Suspension, USP 100,000 units per mL, Cherry/Peppermint Flavor, 16 fl. oz. (473 mL), Rx only,
Pharmaceutical Associates recalls Nystatin Oral Suspension (16 fl oz) due to subpotent drug levels. This means the medication may not be as effective as it should be. Consumers with a prescription should contact their doctor.
Pharmaceutical AssociatesAug 4, 2020 - Lower riskDrug
PAI Holdings, LLC. dba Pharmaceutical Associates Inc recalls Nystatin Oral Suspension, USP, 100,000 units per mL, Cherry/Peppermint Flavor, 16 fl oz (473 mL) bottle, Rx ONLY, pai
Pharmaceutical Associates recalls Nystatin Oral Suspension bottles with low assay results. This subpotent drug may not contain enough active ingredient for effective treatment. Contact for return instructions.
Pharmaceutical AssociatesMar 19, 2020
PAI Holdings, LLC. dba Pharmaceutical Associates Inc recall questions
How many recalls has PAI Holdings, LLC. dba Pharmaceutical Associates Inc had?
7 recalls from PAI Holdings, LLC. dba Pharmaceutical Associates Inc are on record with U.S. safety agencies, from 2020–2025.
What is the most recent PAI Holdings, LLC. dba Pharmaceutical Associates Inc recall?
PAI Holdings, LLC. dba Pharmaceutical Associates Inc recalls Guaifenesin and Codeine Phosphate Oral Solution USP, 100mg/10 mg per 5 mL, 16 fl oz (473 ml) bottles, PAI, dated Jan 7, 2025. Every PAI Holdings, LLC. dba Pharmaceutical Associates Inc recall is listed on this page, newest first.
What should I do if I have a recalled PAI Holdings, LLC. dba Pharmaceutical Associates Inc product?
Match the NDC and lot number on your bottle or box to the recall. Don’t stop a prescription on your own — ask your pharmacist or doctor for a replacement first. Report side effects to FDA MedWatch.
How do I get alerts for new PAI Holdings, LLC. dba Pharmaceutical Associates Inc recalls?
Sign up for free email alerts on GovInfoNow — we check official CPSC, FDA, USDA and NHTSA data every day and email you only when a recall matches what you follow.